Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 20 | $1,324,812 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Sep 2024 17:46 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Sep 2024 | Sale | 500 | 16.33 | 8,165 | D |
| 21 Aug 2024 16:28 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 19 Aug 2024 | Sale | 500 | 15 | 7,500 | D |
| 18 Jul 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Jul 2024 | Sale | 1,750 | 27.11 | 47,442 | D |
| 15 Jul 2024 18:13 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 11 Jul 2024 | Sale | 1,996 | 25 | 49,900 | D |
| 03 Jul 2024 17:11 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Jul 2024 | Sale | 4,248 | 21.3648 | 90,758 | D |
| 20 Jun 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 17 Jun 2024 | Sale | 1,750 | 23.7106 | 41,494 | D |
| 20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 467 | 25.7543 | 12,027 | D |
| 20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 1,283 | 25.342 | 32,514 | D |
| 18 Apr 2024 20:48 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Apr 2024 | Sale | 1,750 | 25.74 | 45,045 | D |
| 03 Apr 2024 19:18 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Apr 2024 | Sale | 8,153 | 31.78 | 259,102 | D |
| 29 Mar 2024 16:52 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Mar 2024 | Sale | 5,833 | 35.0438 | 204,410 | D |
| 20 Mar 2024 16:40 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 18 Mar 2024 | Sale | 1,750 | 31.27 | 54,722 | D |
| 29 Feb 2024 18:01 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Feb 2024 | Sale | 1,909 | 30 | 57,270 | D |
| 21 Feb 2024 17:41 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Feb 2024 | Sale | 1,750 | 27.67 | 48,422 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,996 | 27.5 | 54,890 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 2,916 | 27.5 | 80,190 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,332 | 27.5 | 36,630 | D |
| 12 Jun 2023 18:23 | FMDT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 08 Jun 2023 | Sale | 3,750 | 20.85 | 78,188 | D |
| 06 Jun 2023 19:23 | FMDT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Jun 2023 | Sale | 2,247 | 18.3103 | 41,143 | D |
| 25 Apr 2023 18:44 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 21 Apr 2023 | Sale | 3,750 | 20 | 75,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)